Academic Department of Surgery, Institute of Applied Health Research, University of Birmingham, Birmingham, B15 2TH, United Kingdom.
Anaesthesia. 2024 Jul;79(7):715-724. doi: 10.1111/anae.16220. Epub 2024 Feb 2.
Cardiovascular complications after major surgery are associated with increases in morbidity and mortality. There is confusion over definitions of cardiac injury or complications, and variability in the assessment and management of patients. This international prospective cohort study aimed to define the incidence and timing of these complications and to investigate their impact on 30-day all-cause mortality. We performed a prospective, international cohort study between January 2022 and May 2022. Data were collected on consecutive patients undergoing major abdominal surgery in 446 hospitals from 28 countries across Europe. The primary outcome measure was cardiovascular complications as defined by the Standardised Endpoints for Perioperative Medicine-Core Outcome Measures for Perioperative and Anaesthetic Care initiative up to 30 days after surgery. The secondary outcome was 30-day postoperative mortality. This study included 24,203 patients, of whom 611 (2.5%) developed cardiovascular complications. In total, 458 (1.9%) patients died within 30 days of surgery, of which 123 (26.9%) deaths were judged to be cardiac-related. Mortality rates were higher in patients who developed postoperative cardiovascular complications than in those who did not (19.8% vs. 1.4%), which persisted after risk adjustment (hazard ratio (95%CI) 4.15 (3.14-5.48)). We estimated an absolute risk reduction (95%CI) of 0.4 (0.3-0.5) in mortality in the absence of all cardiovascular complications. This would confer a relative risk reduction in mortality of 21.1% if all cardiovascular complications were prevented. Postoperative cardiovascular complications are relatively common and occur early after major abdominal surgery. However, over 1 in 5 postoperative deaths were attributable to these complications, highlighting an important area for future randomised trials.
术后心血管并发症与发病率和死亡率的增加有关。心脏损伤或并发症的定义存在混淆,患者的评估和管理也存在差异。这项国际前瞻性队列研究旨在定义这些并发症的发生率和时间,并研究其对 30 天全因死亡率的影响。我们在 2022 年 1 月至 2022 年 5 月期间进行了一项前瞻性、国际队列研究。数据来自欧洲 28 个国家的 446 家医院接受大型腹部手术的连续患者。主要结局指标是围手术期医学标准化终点-围手术期和麻醉护理核心结局指标定义的心血管并发症,直到术后 30 天。次要结局是术后 30 天死亡率。这项研究共纳入 24203 例患者,其中 611 例(2.5%)发生心血管并发症。共有 458 例(1.9%)患者在手术后 30 天内死亡,其中 123 例(26.9%)死亡被认为与心脏有关。发生术后心血管并发症的患者死亡率高于未发生心血管并发症的患者(19.8% vs. 1.4%),风险调整后仍如此(危险比(95%CI)4.15(3.14-5.48))。我们估计如果没有发生所有心血管并发症,死亡率的绝对风险降低(95%CI)为 0.4(0.3-0.5)。如果所有心血管并发症都得到预防,死亡率的相对风险降低 21.1%。术后心血管并发症较为常见,发生在大型腹部手术后早期。然而,超过 1/5 的术后死亡归因于这些并发症,这突显了未来随机试验的一个重要领域。